Skip to main navigation Skip to search Skip to main content

CONVERT II An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema: The CONVERT II Trial

Grants and Contracts Details

StatusActive
Effective start/end date4/30/26 → 4/30/28

Funding

  • Pulmonx Corporation: $13,254.00